Tetrahydrocannabinol (THC) is currently a class B controlled drug in the U.K and is illegal.
THC, most commonly known for it’s psychoactive properties, is not recognised as having therapeutic affects under the current law in England and Wales despite numerous studies and case evidence that has shown it to be effective in numerous medical cases.
While researching the effects of Cannabidiol (CBD) I came across numerous sources of information that suggested THC combined with CBD could be an effective treatment for Chronic Obstructive Pulmonary Diesease.
COPD is an umbrella term used to describe progressive lung diseases including emphysema, chronic bronchitis, refractory (non-reversible) asthma, and some forms of bronchitis. This disease is characterised by increased breathlessness that causes air flow limitation to the lungs.
From the research and information I have gathered it has been shown that THC when combined with CBD could be an effective treatment for this type of condition and could help slow the progression of the condition and it’s symptoms.
Studies have shown that THC has anti-inflammatory benefits, it inhibits enzymes responsible for the production of inflammatory molecules which contribute to airway inflammation and opens up the airways. It also reduces allergen-induced mucus production which is a common symptom of COPD.
Vey Linville discusses using Marijuana to treat his severe emphysema
Studies have also shown that CBD is a powerful antioxidant that decreases lung resistance, leukocyte migration in the lungs (leukocytes are involved in counteracting foreign substances and disease), Myeloperoxidase (MPO) activity in the lung tissue (MPO is an enzyme that produces hypohalous acids that carry out antimicrobial activities, studies have reported an association in elevated levels of MPO and the severity of coronary disease), protein concentration and production of pro-inflammatory cytokines (cytokines are important in health and disease, specifically in response to infection and inflammation).
Out of the two phytocannabinoids studies show that THC is the most effective when treating COPD but a combination of the two has a better therapeutic effect. THC and CBD both work in synergy at the area of inflammation and Cannabis products containing both THC and CBD have been shown to improve sleep patterns, increase the function of the immune system, provide pain relief regarding the chest and lung regions and reduce mucous and phlemn production all of which would seem an effective treatment for COPD.
Unfortunately cannabis products with a THC content above <0.2% are illegal in England and Wales and until the laws are changed CBD is the only option some people have and it is 100% legal buy and consume in the U.K.